Nicotinamide adenine dinucleotide (NAD+) is both a redox cofactor and a signaling substrate that couples energy state to stress response, chromatin state, DNA repair, neuroinflammation, and proteostasis.[@verdin2015][verdin2015 2015, verdin2015](https://pubmed.ncbi.nlm.nih.gov/26466563/)[lautrup2019 2019, lautrup2019](https://pubmed.ncbi.nlm.nih.gov/31748358/) In the aging brain, NAD+ pools decline across [neurons](/entities/neurons), glia, and vascular cells, producing a systems-level vulnerability pattern that overlaps with Alzheimer disease (AD), Parkinson disease (PD), and 4R-[tau](/proteins/tau) disorders such as corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP).[@lautrup2019][lautrup2019 2019, lautrup2019](https://pubmed.ncbi.nlm.nih.gov/31748358/)[hou2021 2021, hou2021](https://pubmed.ncbi.nlm.nih.gov/33738450/)
Unlike purely metabolic pathways, NAD+ signaling is substrate-limited: once NAD+ falls below a functional threshold, competing enzymes (notably [Sirtuin signaling](/mechanisms/sirtuin-signaling-pathway), [PARP-mediated DNA damage response](/mechanisms/dna-damage-response-impairment-pathway), and CD38/CD157 ectoenzymes) begin to trade off against each other. The consequence is a feed-forward cycle of mitochondrial inefficiency, impaired DNA maintenance, inflammatory amplification, and reduced neuronal resilience.[@cant2015][verdin2015 2015, verdin2015](https://pubmed.ncbi.nlm.nih.gov/26466563/)[cant2015 2015, cant2015](https://pubmed.ncbi.nlm.nih.gov/26118927/)
Nicotinamide adenine dinucleotide (NAD+) is both a redox cofactor and a signaling substrate that couples energy state to stress response, chromatin state, DNA repair, neuroinflammation, and proteostasis.[@verdin2015][verdin2015 2015, verdin2015](https://pubmed.ncbi.nlm.nih.gov/26466563/)[lautrup2019 2019, lautrup2019](https://pubmed.ncbi.nlm.nih.gov/31748358/) In the aging brain, NAD+ pools decline across [neurons](/entities/neurons), glia, and vascular cells, producing a systems-level vulnerability pattern that overlaps with Alzheimer disease (AD), Parkinson disease (PD), and 4R-[tau](/proteins/tau) disorders such as corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP).[@lautrup2019][lautrup2019 2019, lautrup2019](https://pubmed.ncbi.nlm.nih.gov/31748358/)[hou2021 2021, hou2021](https://pubmed.ncbi.nlm.nih.gov/33738450/)
Unlike purely metabolic pathways, NAD+ signaling is substrate-limited: once NAD+ falls below a functional threshold, competing enzymes (notably [Sirtuin signaling](/mechanisms/sirtuin-signaling-pathway), [PARP-mediated DNA damage response](/mechanisms/dna-damage-response-impairment-pathway), and CD38/CD157 ectoenzymes) begin to trade off against each other. The consequence is a feed-forward cycle of mitochondrial inefficiency, impaired DNA maintenance, inflammatory amplification, and reduced neuronal resilience.[@cant2015][verdin2015 2015, verdin2015](https://pubmed.ncbi.nlm.nih.gov/26466563/)[cant2015 2015, cant2015](https://pubmed.ncbi.nlm.nih.gov/26118927/)
Sirtuins are NAD+-dependent deacylases that function as energy-sensitive transcriptional and metabolic rheostats. In the CNS:
Poly(ADP-ribose) polymerases (especially PARP1) consume NAD+ to support DNA repair. In chronic oxidative stress states, PARP activity can become maladaptively high, effectively siphoning NAD+ away from sirtuins and mitochondrial maintenance.[berger2021 2021, berger2021](https://pubmed.ncbi.nlm.nih.gov/32801110/)[fang2019 2019, fang2019](https://pubmed.ncbi.nlm.nih.gov/30664688/) This creates a substrate competition problem:
This loop is one mechanistic bridge between oxidative injury and progressive neuronal dysfunction.[berger2021 2021, berger2021](https://pubmed.ncbi.nlm.nih.gov/32801110/)[madan2023 2023, madan2023](https://pubmed.ncbi.nlm.nih.gov/35238124/)
CD38 and CD157 metabolize NAD+ into signaling metabolites (including cADPR) that reshape calcium dynamics and immune-cell activation states.[chini2017 2017, NAD and the aging process: role of CD38, Sirtuins, and PARP](https://pubmed.ncbi.nlm.nih.gov/29021061/) In aging and neuroinflammatory conditions, CD38 upregulation is associated with accelerated NAD+ depletion and glial activation.[chini2017 2017, NAD and the aging process: role of CD38, Sirtuins, and PARP](https://pubmed.ncbi.nlm.nih.gov/29021061/)[camachopereira2016 2016, camachopereira2016](https://pubmed.ncbi.nlm.nih.gov/28065803/) From a pathway perspective, CD38 behaves as both a marker and a driver of the inflammatory-metabolic transition.
The brain relies heavily on salvage synthesis to maintain NAD+:
NAD+ signaling is compartment-dependent rather than uniform. Cytosolic, nuclear, and mitochondrial pools are functionally coupled but kinetically distinct, so a systemic rise in blood NAD+ does not guarantee adequate restoration inside vulnerable neuronal compartments.[lautrup2019 2019, lautrup2019](https://pubmed.ncbi.nlm.nih.gov/31748358/)[cant2015 2015, cant2015](https://pubmed.ncbi.nlm.nih.gov/26118927/)[yoshino2018 2018, NAD+ intermediates: the biology and therapeutic potential of NMN and NR](https://pubmed.ncbi.nlm.nih.gov/29311726/)
The nucleus is a high-demand NAD+ sink during genotoxic stress because PARPs and sirtuins co-compete for substrate. Under chronic DNA damage pressure, PARP-dominant states can reduce nuclear NAD+ availability for SIRT1/SIRT6-dependent transcriptional adaptation and chromatin repair.[kugel2014 2014, Chromatin and beyond: the multitasking roles for SIRT6](https://pubmed.ncbi.nlm.nih.gov/24529338/)[berger2021 2021, berger2021](https://pubmed.ncbi.nlm.nih.gov/32801110/)[chini2017 2017, NAD and the aging process: role of CD38, Sirtuins, and PARP](https://pubmed.ncbi.nlm.nih.gov/29021061/)
Mitochondrial NAD+ supports oxidative phosphorylation and SIRT3-dependent deacetylation programs that preserve electron transport chain function, antioxidant buffering, and mitophagy competence.[pillai2015 2015, pillai2015](https://pubmed.ncbi.nlm.nih.gov/21664487/)[fang2019 2019, fang2019](https://pubmed.ncbi.nlm.nih.gov/30664688/)[madan2023 2023, madan2023](https://pubmed.ncbi.nlm.nih.gov/35238124/) In neurons with long axonal arbors and high pacemaker load, small deficits in mitochondrial NAD+ handling can produce large downstream energy penalties.
Cytosolic NAD+ dynamics influence glycolytic reserve and calcium-linked stress signaling, while membrane-proximal CD38 activity can locally accelerate extracellular and pericellular NAD+ turnover in inflammatory contexts.[chini2017 2017, NAD and the aging process: role of CD38, Sirtuins, and PARP](https://pubmed.ncbi.nlm.nih.gov/29021061/)[camachopereira2016 2016, camachopereira2016](https://pubmed.ncbi.nlm.nih.gov/28065803/) This contributes to glia-neuron coupling failure in chronic neuroinflammatory states.
Total NAD+ abundance and NAD+/NADH ratio are related but not equivalent. The ratio informs metabolic directionality, mitochondrial electron pressure, and stress-pathway activation thresholds.[verdin2015 2015, verdin2015](https://pubmed.ncbi.nlm.nih.gov/26466563/)[cant2015 2015, cant2015](https://pubmed.ncbi.nlm.nih.gov/26118927/)
In practical terms:
AD combines amyloid stress, tau pathology, synaptic failure, and glial dysregulation. NAD+ signaling intersects each domain:
Dopaminergic neurons in [Substantia nigra pars compacta](/cell-types/substantia-nigra-pars-compacta-motor) have high oxidative load and strict mitochondrial requirements. In PD models, NAD+ repletion improves mitochondrial bioenergetics and supports mitophagy-linked quality control.[schndorf2018 2018, schndorf2018](https://pubmed.ncbi.nlm.nih.gov/28696412/)[brakedal2022 2022, brakedal2022](https://pubmed.ncbi.nlm.nih.gov/35027767/)
NAD+ signaling also interfaces with [alpha-synuclein](/proteins/alpha-synuclein) stress: metabolic fragility and proteostatic strain co-amplify each other, making substrate restoration potentially useful in combination with proteostasis-targeting strategies.[lautrup2019 2019, lautrup2019](https://pubmed.ncbi.nlm.nih.gov/31748358/)[lautrup2019a 2019, NAD+ in brain aging and neurodegenerative disorders: from mechanisms to thera...](https://pubmed.ncbi.nlm.nih.gov/31577933/)
CBS and PSP are dominated by tau-driven network degeneration with pronounced glial and brainstem involvement. NAD+ biology is relevant through several channels:
NAD+ signaling should be viewed as a coupling layer between [Mitochondrial dysfunction pathway](/mechanisms/mitochondrial-dysfunction-pathway), [Autophagy-lysosomal pathway](/mechanisms/autophagy-lysosomal-pathway), and [Neuroinflammation pathway](/mechanisms/neuroinflammation-pathway).
Key coupling effects:
NAD+ stress is not distributed uniformly across CNS cell classes.
Large projection neurons (corticospinal, nigrostriatal, and frontostriatal systems) carry high ATP demand and long-distance transport burdens, making them sensitive to NAD+-dependent mitochondrial inefficiency and transport failure.[lautrup2019 2019, lautrup2019](https://pubmed.ncbi.nlm.nih.gov/31748358/)[schndorf2018 2018, schndorf2018](https://pubmed.ncbi.nlm.nih.gov/28696412/)[brakedal2022 2022, brakedal2022](https://pubmed.ncbi.nlm.nih.gov/35027767/)
Activated glia can become major determinants of local NAD+ turnover through inflammatory CD38 induction and cytokine-driven metabolic rewiring. This can produce local substrate depletion and sustain inflammatory feed-forward loops that damage neighboring neurons.[chini2017 2017, NAD and the aging process: role of CD38, Sirtuins, and PARP](https://pubmed.ncbi.nlm.nih.gov/29021061/)[camachopereira2016 2016, camachopereira2016](https://pubmed.ncbi.nlm.nih.gov/28065803/)
Myelin maintenance and axonal metabolic support are energy-intensive. While human evidence remains less mature than in neuronal models, NAD+ pressure likely contributes to white-matter vulnerability where mitochondrial reserve is already marginal.[lautrup2019 2019, lautrup2019](https://pubmed.ncbi.nlm.nih.gov/31748358/)[hou2021 2021, hou2021](https://pubmed.ncbi.nlm.nih.gov/33738450/)
NAD+ precursor classes:
Potentially complementary strategies:
For translational programs, dose selection should target demonstrable NAD+ engagement rather than fixed nutraceutical conventions. A useful sequence:
Safety and interpretive guardrails:
Future CNS trials should prioritize:
A multi-layer biomarker stack can separate pharmacologic failure from biological non-responsiveness:
Important unresolved points:
A practical translational framework for CBS/PSP studies:
This approach can reduce false negatives caused by underdosing or biologically unengaged cohorts.
| Dimension | Current confidence | Rationale |
|---|---|---|
| Mechanistic coherence | Moderate-High | Strong convergence of sirtuin/PARP/CD38 competition and mitochondrial coupling |
| Preclinical reproducibility | Moderate | Multiple models show directionally consistent metabolic rescue, with model-specific effect sizes |
| Human target engagement | Moderate-High | Peripheral NAD+ and related metabolite shifts are repeatedly demonstrable |
| Clinical efficacy certainty | Low-Moderate | Signals exist, but definitive disease-modifying outcomes remain limited |
| Actionability today | Moderate | Reasonable for biomarker-guided adjunctive use; premature as stand-alone disease-modifying therapy |
Overall interpretation: NAD+ signaling is one of the most coherent metabolism-linked pathways in neurodegeneration, but translation requires biomarker-anchored precision rather than generalized supplementation assumptions.[lautrup2019 2019, lautrup2019](https://pubmed.ncbi.nlm.nih.gov/31748358/)[hou2021 2021, hou2021](https://pubmed.ncbi.nlm.nih.gov/33738450/)[yoshino2018 2018, NAD+ intermediates: the biology and therapeutic potential of NMN and NR](https://pubmed.ncbi.nlm.nih.gov/29311726/)[martens2018 2018, martens2018](https://pubmed.ncbi.nlm.nih.gov/29513214/)